Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
53
Number of overlapping holdings
14.8%
% of FHLC's 372 holdings also in WDNA
59.6%
% of WDNA's 91 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 1.3% | 1.3% |
|
DANAHER CORP | 2.9% | 1.3% | 1.3% |
|
REGENERON PHARMACEUTICALS | 1.7% | 1.2% | 1.2% |
|
ZOETIS INC | 1.4% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to WDNA
|
ELI LILLY & CO | 8.3% |
|
UNITEDHEALTH GROUP INC | 7.3% |
|
JOHNSON & JOHNSON | 5.3% |
|
ABBVIE INC | 5.1% |
|
MERCK & CO. INC. | 4.1% |
|
ABBOTT LABORATORIES | 3.3% |
|
THERMO FISHER SCIENTIFIC INC | 2.5% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
STRYKER CORP | 2.0% |
|
ELEVANCE HEALTH INC | 1.9% |
FHLC Underweight Relative to WDNA
|
IOVANCE BIOTHERAPEUTICS INC | -3.8% |
|
TWIST BIOSCIENCE CORP. | -3.3% |
|
FATE THERAPEUTICS INC | -3.1% |
 |
NOVOZYMES A/S-B SHARES | -2.4% |
|
BLUEPRINT MEDICINES CORP. | -2.1% |
|
BRIDGEBIO PHARMA, INC. | -2.0% |
|
NATERA INC | -1.8% |
|
CRISPR THERAPEUTICS AG | -1.7% |
 |
ALCOBRA LTD | -1.7% |
|
CARIBOU BIOSCIENCES, INC. | -1.6% |